4
Changes in Ownership
Cue Biopharma, Inc. Filed Acc 0001209191-18-045024
Options or other derivatives
- SVP and Chief Business Officer acquired 250,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mancilla Bethany SVP and Chief Business Officer | 2018-08-01 | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…